Patients News | pharmaphorum

News

Study will gauge impact of 'at-risk' ALS patient testing

Sano Genetics has been awarded a grant from Innovate UK to explore the psychological impact on people at risk of motor neurone disease (MND) – also known as amyotrophic la

News

NICE unconvinced by CSL's haemophilia B gene therapy

The UK's National Institute for Health and Care Excellence (NICE) has said it is minded not to recommend approval of CSL Behring and uniQure's Hemgenix gene therapy for ha

News

Thermo agrees settlement with Henrietta Lacks' family

The family of Henrietta Lacks, an African American woman whose cells have been used in research for decades but were allegedly harvested without her consent, has agreed to

News

AI shows its value in mammography screening

A study has shown that artificial intelligence can be safely used to support mammography to spot breast cancers and may spot more tumours than the current standard approac

News

Apellis slides on side effect reports with new eye drug

Apellis' share price came under pressure today after it revealed new details about a rare but serious side effect with its recently-approved Syfovre therapy for eye diseas

News

Purdue bankruptcy case elevated to SCOTUS

The US Government has asked the Supreme Court to block Purdue Pharma from completing a bankruptcy settlement that would shield its Sackler family owners from lawsuits.

Study will gauge impact of 'at-risk' ALS patient testing

NICE unconvinced by CSL's haemophilia B gene therapy

Thermo agrees settlement with Henrietta Lacks' family

AI shows its value in mammography screening

Apellis slides on side effect reports with new eye drug

Purdue bankruptcy case elevated to SCOTUS

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks